Total Funding
1
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Cylene Pharmaceuticals discovers, develops and commercializes small molecule drugs that target nucleolus and kill cancer cells.
About the Company
Cylene Pharmaceuticals is a biotech pharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs that target the nucleolus and kill cancer cells. It offers nucleolus-targeting agents, which are small-molecule targeted cancer therapeutic agents for carcinoid/neuroendocrine tumors and pediatric
brain tumors, and serine/threonine protein kinase inhibitors. The company also provides preclinical-stage oral drug candidates. Cylene Pharmaceuticals was founded in 1997 as Cyternex, Inc., and changed its name to Cylene Pharmaceuticals in October 2003. The company is based in San Diego, California.
